Research & Literature

Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF).

Lala A, McNulty SE, Mentz RJ, et al.

Circulation. Heart failure 2015; (8(4)):741-8 doi:10.1161/CIRCHEARTFAILURE.114.001957.

Congestive Heart Failure.

Scott MC, Winters ME

Emergency medicine clinics of North America 2015; (33(3)):553-62.

Management of Patients Admitted with Acute Decompensated Heart Failure.

Krim SR, Campbell PT, Desai S, et al.

Ochsner journal 2015; (15(3)):284-9.

Medication Adherence Interventions Improve Heart Failure Mortality and Readmission Rates: Systematic Review and Meta-Analysis of Controlled Trials.

Ruppar TM, Cooper PS, Mehr DR, et al.

Journal of the American Heart Association 2016; (5(6)).

Fluid Volume Overload and Congestion in Heart Failure: Time to Reconsider Pathophysiology and How Volume Is Assessed.

Miller WL

Circulation. Heart failure 2016; (9(8)):e002922 doi:10.1161/CIRCHEARTFAILURE.115.002922.

Influence of influenza vaccination on recurrent hospitalization in patients with heart failure.

Kaya H, Beton O, Acar G, et al.

Herz 2017; (42(3)):307-315 doi:10.1007/s00059-016-4460-2.

Usefulness of Palliative Care to Complement the Management of Patients on Left Ventricular Assist Devices.

Luo N, Rogers JG, Dodson GC, et al.

The American journal of cardiology 2016; (118(5)):733-8.

Defibrillators: Selecting the Right Device for the Right Patient.

Al-Khatib SM, Friedman P, Ellenbogen KA

Circulation 2016; (134(18)):1390-1404 doi:10.1161/CIRCULATIONAHA.116.021889.

Burden of Recurrent Hospitalizations Following an Admission for Acute Heart Failure: Preserved Versus Reduced Ejection Fraction.

Santas E, Valero E, Mollar A, et al.

Revista espanola de cardiologia (English ed.) 2017; (70(4)):239-246 doi:10.1016/j.rec.2016.06.021.

Dietary Self-management in Heart Failure: High Tech or High Touch?

Colin-Ramirez E, Arcand J, Ezekowitz JA

Current treatment options in cardiovascular medicine 2017; (19(3)):19 doi:10.1007/s11936-017-0515-9.

Renal sodium avidity in heart failure: from pathophysiology to treatment strategies.

Mullens W, Verbrugge FH, Nijst P, Tang WHW

European heart journal 2017; (38(24)):1872-1882 doi:10.1093/eurheartj/ehx035.

Heart failure.

Metra M, Teerlink JR

Lancet (London, England) 2017; (390(10106)):1981-1995 doi:10.1016/S0140-6736(17)31071-1.

Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes.

Shah KS, Xu H, Matsouaka RA, et al.

Journal of the American College of Cardiology 2017; (70(20)):2476-2486 doi:10.1016/j.jacc.2017.08.074.

Signs and symptoms in adult patients with acute dyspnea: a systematic review and meta-analysis.

Renier W, Winckelmann KH, Verbakel JY, et al.

European journal of emergency medicine : official journal of the European Society for Emergency Medicine 2018; (25(1)):3-11 doi:10.1097/MEJ.0000000000000429.

N-Terminal Pro-B-Type Natriuretic Peptide in the Emergency Department: The ICON-RELOADED Study.

Januzzi JL, Chen-Tournoux AA, Christenson RH, et al.

Journal of the American College of Cardiology 2018; (71(11)):1191-1200 doi:10.1016/j.jacc.2018.01.021.

Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure.

Rubio-Gracia J, Demissei BG, Ter Maaten JM, et al.

International journal of cardiology 2018; (258()):185-191 doi:10.1016/j.ijcard.2018.01.067.

Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology.

Crespo-Leiro MG, Metra M, Lund LH, et al.

European journal of heart failure 2018; (20(11)):1505-1535 doi:10.1002/ejhf.1236.

Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.

Martin N, Manoharan K, Thomas J, et al.

The Cochrane database of systematic reviews 2018; (6()):CD012721 doi:10.1002/14651858.CD012721.pub2.

Heart Failure With Improved Ejection Fraction: Is it Possible to Escape One's Past?

Gulati G, Udelson JE

JACC. Heart failure 2018; (6(9)):725-733 doi:10.1016/j.jchf.2018.05.004.

A Bayesian Model to Predict Survival After Left Ventricular Assist Device Implantation.

Kanwar MK, Lohmueller LC, Kormos RL, et al.

JACC. Heart failure 2018; (6(9)):771-779 doi:10.1016/j.jchf.2018.03.016.

Reduction in mortality from implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy patients is dependent on the presence of left ventricular scar.

Gutman SJ, Costello BT, Papapostolou S, et al.

European heart journal 2019; (40(6)):542-550 doi:10.1093/eurheartj/ehy437.

Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial.

Koehler F, Koehler K, Deckwart O, et al.

Lancet (London, England) 2018; (392(10152)):1047-1057 doi:10.1016/S0140-6736(18)31880-4.

Influenza Vaccine in Heart Failure.

Modin D, Jørgensen ME, Gislason G, et al.

Circulation 2019; (139(5)):575-586 doi:10.1161/CIRCULATIONAHA.118.036788.

Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21 334 patients in the UK.

Linde C, Qin L, Bakhai A, et al.

ESC heart failure 2019; (6(2)):280-290 doi:10.1002/ehf2.12402.

Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction.

Greene SJ, Fonarow GC, DeVore AD, et al.

Journal of the American College of Cardiology 2019; (73(19)):2365-2383 doi:10.1016/j.jacc.2019.02.015.

Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure.

Savarese G, Vedin O, D'Amario D, et al.

JACC. Heart failure 2019; (7(4)):306-317 doi:10.1016/j.jchf.2018.11.019.

Change in indication for cardiac resynchronization therapy?

Lawin D, Stellbrink C

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2019; (55(Suppl 1)):i11-i16 doi:10.1093/ejcts/ezy488.

Change in renal function associated with drug treatment in heart failure: national guidance.

Clark AL, Kalra PR, Petrie MC, et al.

Heart (British Cardiac Society) 2019; (105(12)):904-910 doi:10.1136/heartjnl-2018-314158.

Psychosocial Evaluation of Candidates for Heart Transplant and Ventricular Assist Devices: Beyond the Current Consensus.

Bui QM, Allen LA, LeMond L, et al.

Circulation. Heart failure 2019; (12(7)):e006058 doi:10.1161/CIRCHEARTFAILURE.119.006058.

Patient Selection for Destination LVAD Therapy: Predicting Success in the Short and Long Term.

Michaels A, Cowger J

Current heart failure reports 2019; (16(5)):140-149 doi:10.1007/s11897-019-00434-1.

How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).

Pieske B, Tschöpe C, de Boer RA, et al.

European heart journal 2019; (40(40)):3297-3317 doi:10.1093/eurheartj/ehz641.

Diagnosis of Acute Heart Failure in the Emergency Department: An Evidence-Based Review.

Long B, Koyfman A, Gottlieb M

The western journal of emergency medicine 2019; (20(6)):875-884 doi:10.5811/westjem.2019.9.43732.

Hyperkalemia: pathophysiology, risk factors and consequences.

Hunter RW, Bailey MA

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2019; (34(Suppl 3)):iii2-iii11 doi:10.1093/ndt/gfz206.

Acute heart failure.

Arrigo M, Jessup M, Mullens W, et al.

Nature reviews. Disease primers 2020; (6(1)):16 doi:10.1038/s41572-020-0151-7.

Acute Decompensated Heart Failure in Patients with Heart Failure with Reduced Ejection Fraction.

Fukata M

Heart failure clinics 2020; (16(2)):187-200 doi:10.1016/j.hfc.2019.12.007.

Evaluation for Heart Transplantation and LVAD Implantation: JACC Council Perspectives.

Guglin M, Zucker MJ, Borlaug BA, et al.

Journal of the American College of Cardiology 2020; (75(12)):1471-1487 doi:10.1016/j.jacc.2020.01.034.

Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials.

Vaduganathan M, Claggett BL, Jhund PS, et al.

Lancet (London, England) 2020; (396(10244)):121-128 doi:10.1016/S0140-6736(20)30748-0.

Practical management of worsening renal function in outpatients with heart failure and reduced ejection fraction: Statement from a panel of multidisciplinary experts and the Heart Failure Working Group of the French Society of Cardiology.

Mewton N, Girerd N, Boffa JJ, et al.

Archives of cardiovascular diseases 2020; (113(10)):660-670 doi:10.1016/j.acvd.2020.03.018.

Serum potassium and heart failure: association, causation, and clinical implications.

Sfairopoulos D, Arseniou A, Korantzopoulos P

Heart failure reviews 2021; (26(3)):479-486 doi:10.1007/s10741-020-10039-9.

Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association.

Bozkurt B, Coats AJS, Tsutsui H, et al.

European journal of heart failure 2021; (23(3)):352-380 doi:10.1002/ejhf.2115.

Universal Definition and Classification of Heart Failure.

Bozkurt B, Coats A, Tsutsui H

Journal of cardiac failure 2021; doi:10.1016/j.cardfail.2021.01.022.

Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure.

Bozkurt B, Coats AJ, Tsutsui H, et al.

Journal of cardiac failure 2021; (27(4)):387-413 doi:10.1016/j.cardfail.2021.01.022.

Rapid evidence-based sequencing of foundational drugs for heart failure and a reduced ejection fraction.

Packer M, McMurray JJV

European journal of heart failure 2021; (23(6)):882-894 doi:10.1002/ejhf.2149.

The dawn of the four-drug era? SGLT2 inhibition in heart failure with reduced ejection fraction.

Genuardi MV, Mather PJ

Therapeutic advances in cardiovascular disease 2021; (15()):17539447211002678 doi:10.1177/17539447211002678.

Optimal diuretic strategies in heart failure.

Suri SS, Pamboukian SV

Annals of translational medicine 2021; (9(6)):517 doi:10.21037/atm-20-4600.

Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial.

Solomon SD, de Boer RA, DeMets D, et al.

European journal of heart failure 2021; (23(7)):1217-1225 doi:10.1002/ejhf.2249.

History of heart failure in patients with coronavirus disease 2019: Insights from a French registry.

Panagides V, Vincent F, Weizman O, et al.

Archives of cardiovascular diseases 2021; (114(5)):415-425 doi:10.1016/j.acvd.2021.04.003.

Improving Diuretic Response in Heart Failure by Implementing a Patient-Tailored Variability and Chronotherapy-Guided Algorithm.

Kenig A, Kolben Y, Asleh R, et al.

Frontiers in cardiovascular medicine 2021; (8()):695547 doi:10.3389/fcvm.2021.695547.

Guidance for Timely and Appropriate Referral of Patients With Advanced Heart Failure: A Scientific Statement From the American Heart Association.

Morris AA, Khazanie P, Drazner MH, et al.

Circulation 2021; (144(15)):e238-e250 doi:10.1161/CIR.0000000000001016.

Angiotensin receptor blocker neprilysin inhibitors.

Usuda D, Higashikawa T, Hotchi Y, et al.

World journal of cardiology 2021; (13(8)):325-339 doi:10.4330/wjc.v13.i8.325.

Weight Surveillance and Heart Failure Self-assessment in Patients with Chronic Leg Wounds: A Pilot Study.

Stecker J, Schwinck J

Advances in skin & wound care 2022; (35(2)):1-6 doi:10.1097/01.ASW.0000805364.01790.64.

Heart failure with mildly reduced ejection fraction: emerging frontiers in clinical characteristics, prognosis, and treatment.

Shang Z, Wang X, Gao W

Reviews in cardiovascular medicine 2022; (23(1)):30 doi:10.31083/j.rcm2301030.

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Heidenreich PA, Bozkurt B, Aguilar D, et al.

Journal of the American College of Cardiology 2022; (79(17)):e263-e421 doi:10.1016/j.jacc.2021.12.012.

Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial.

Ezekowitz JA, Colin-Ramirez E, Ross H, et al.

Lancet (London, England) 2022; (399(10333)):1391-1400 doi:10.1016/S0140-6736(22)00369-5.

Congestive Heart Failure.

Chen J, Aronowitz P

The Medical clinics of North America 2022; (106(3)):447-458 doi:10.1016/j.mcna.2021.12.002.

SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials.

Vaduganathan M, Docherty KF, Claggett BL, et al.

Lancet (London, England) 2022; (400(10354)):757-767 doi:10.1016/S0140-6736(22)01429-5.

The interstitial compartment as a therapeutic target in heart failure.

Aronson D

Frontiers in cardiovascular medicine 2022; (9()):933384 doi:10.3389/fcvm.2022.933384.

Iatrogenic Arteriovenous Fistula Secondary to Percutaneous Coronary Intervention Causing Severe Decompensated Heart Failure.

Kasliwal N, Pfeiffer WB, Eidt JF, et al.

Cureus 2022; (14(8)):e27934 doi:10.7759/cureus.27934.

Edema formation in congestive heart failure and the underlying mechanisms.

Abassi Z, Khoury EE, Karram T, Aronson D

Frontiers in cardiovascular medicine 2022; (9()):933215 doi:10.3389/fcvm.2022.933215.

Sodium-glucose co-transporter 2 inhibitors in heart failure with mildly reduced or preserved ejection fraction: an updated systematic review and meta-analysis.

Wang Y, Gao T, Meng C, et al.

European journal of medical research 2022; (27(1)):314 doi:10.1186/s40001-022-00945-z.

Joint modeling of longitudinal change in pulse rate and survival time of heart failure patients treated at Arbaminch General Hospital, Southern Ethiopia.

Anjullo BB, Kumaso SK, Erango MA

PloS one 2023; (18(3)):e0282637 doi:10.1371/journal.pone.0282637.

Practical algorithms for early diagnosis of heart failure and heart stress using NT-proBNP: A clinical consensus statement from the Heart Failure Association of the ESC.

Bayes-Genis A, Docherty KF, Petrie MC, et al.

European journal of heart failure 2023; (25(11)):1891-1898 doi:10.1002/ejhf.3036.

Fluid balance in heart failure.

Cosentino N, Marenzi G, Muratori M, et al.

European journal of preventive cardiology 2023; (30(Suppl 2)):ii9-ii15 doi:10.1093/eurjpc/zwad166.

Dietary sodium and fluid intake in heart failure. A clinical consensus statement of the Heart Failure Association of the ESC.

Mullens W, Damman K, Dhont S, et al.

European journal of heart failure 2024; (26(4)):730-741 doi:10.1002/ejhf.3244.

Therapy duration and improvement of ventricular function in de novo heart failure: the Heart Failure Optimization study.

Veltmann C, Duncker D, Doering M, et al.

European heart journal 2024; (45(30)):2771-2781 doi:10.1093/eurheartj/ehae334.

How to Optimize Goal-Directed Medical Therapy (GDMT) in Patients with Heart Failure.

Newman E, Kamanu C, Gibson G, Brailovsky Y

Current cardiology reports 2024; (26(9)):995-1003 doi:10.1007/s11886-024-02101-x.

Sequencing Quadruple Therapy for Heart Failure with Reduced Ejection Fraction: Does It Really Matter?

Hu JR, Schwann AN, Tan JW, et al.

Heart failure clinics 2024; (20(4)):373-386 doi:10.1016/j.hfc.2024.06.004.

Long-term follow-up of the TRED-HF trial: Implications for therapy in patients with dilated cardiomyopathy and heart failure remission.

Cheng L, Hammersley D, Ragavan A, et al.

European journal of heart failure 2025; (27(1)):113-123 doi:10.1002/ejhf.3475.

An Observational Study of Evidence-Based Therapies in Older Patients with Heart Failure with Reduced Ejection Fraction: Insights from a Dedicated Heart Failure Clinic.

Araújo CS, Marco I, Restrepo-Córdoba MA, et al.

Journal of clinical medicine 2024; (13(23)) doi:10.3390/jcm13237171.

Management of Heart Failure With Improved Ejection Fraction: Current Evidence and Controversies.

Kodur N, Tang WHW

JACC. Heart failure 2025; (13(4)):537-553 doi:10.1016/j.jchf.2025.02.007.

Vaccination in patients with heart failure in practice.

Roubille F, Chapet N, Roubille C, et al.

European journal of preventive cardiology 2025; doi:10.1093/eurjpc/zwaf366.

Withdrawal of Spironolactone for Heart Failure With Improved Ejection Fraction: An Open-Label, Pilot, Randomized Controlled Trial (With-HF Trial).

Hyun J, Lee SA, Lee SE, et al.

Korean circulation journal 2025; (55(12)):1077-1089 doi:10.4070/kcj.2025.0052.

SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI.

Metra M, Tomasoni D, Adamo M, et al.

ESC heart failure 2025; (12(6)):3806-3825 doi:10.1002/ehf2.15408.

Heart failure with reduced ejection fraction.

Cannata A, Crespo-Leiro MG, Bromage DI, et al.

Lancet (London, England) 2026; (407(10527)):529-542 doi:10.1016/S0140-6736(25)01851-3.

Heart failure in the Portuguese population aged ≥50 years: prevalence and phenotypes in the PORTHOS study.

Baptista R, Rodrigues AM, Bernardo F, et al.

European heart journal 2026; doi:10.1093/eurheartj/ehag030.

Access to medical care globally for patients with peripartum cardiomyopathy: a clinical consensus statement of the Heart Failure Association of the ESC.

Sliwa K, Viljoen C, Hoevelmann J, et al.

European journal of heart failure 2026; (28(2)):315-325 doi:10.1093/ejhf/xuag024.

Acute Estimated Glomerular Filtration Rate Decline After Initiation of Therapies That Slow Kidney Disease Progression: Clinical Practice Implications.

Cherney DZI, Alicic RZ, Bonaca MP

Mayo Clinic proceedings 2026; (101(8)):1347-1366 doi:10.1016/j.mayocp.2026.01.010.

Anthropometric adiposity measures and natriuretic peptides in heart failure screening: population-based evidence from the PORTHOS study.

Gavina C, Ferreira JP, Mendes LL, et al.

European journal of heart failure 2026; doi:10.1093/ejhf/xuag154.

Biomarkers in heart failure.

Garofalo M, Panichella G, Aimo A

Advances in clinical chemistry 2026; (134()):1-46 doi:10.1016/bs.acc.2026.03.005.